Net profit of Jagsonpal Pharmaceuticals declined 65.77% to Rs 10.95 crore in the quarter ended December 2025 as against Rs 31.99 crore during the previous quarter ended December 2024. Sales declined 1.46% to Rs 72.95 crore in the quarter ended December 2025 as against Rs 74.03 crore during the previous quarter ended December 2024.
| Particulars | Quarter Ended |
| Dec. 2025 | Dec. 2024 | % Var. |
| Sales | 72.95 | 74.03 | -1 |
| OPM % | 22.30 | 21.38 | - |
| PBDT | 18.99 | 17.90 | 6 |
| PBT | 16.60 | 15.49 | 7 |
| NP | 10.95 | 31.99 | -66 |